JD Wetherspoon today said warm weather boosted trading after reporting a 5.1% rise in like-for-like sales for the 12 weeks to ...

The enterprise suite introduces four key AI agents – finance, payments, accounting and project management – each designed to ...

Find insight on Bruker, Sartorius, Sarepta and more in the latest Market Talks covering Health Care.

GSK shares fell after a Food and Drug Administration advisory committee voted against approval of the company's Blenrep drug, a setback for its bid to reintroduce the blood-cancer treatment in the U.S ...

FTSE 100 Live Friday Reckitt sells Cillit BangBurberry hails progressBP sells onshore wind business Market update: GSK falls 6% on FDA setback, Burberry ...

This summary highlights significant events in the health sector, including Johnson & Johnson's profit boost from Darzalex, safety concerns for GSK's cancer drug, refugee malnutrition in Gaza, KKR's ...

Explore Matthews International Corporation's restructuring efforts, asset sales, and challenges in reducing debt. Click for ...

With GSK kicking its research and development engine into high gear in recent years, a shuffling of the scientific priorities is only natural. | With GSK kicking its R&D engine into high gear in ...

AWS upgraded its SageMaker platform to offer more observability and streamlined functions to make AI model inference and training easier.

GSK PLC GSK shares rose 1.33% to £14.14 Tuesday, on what proved to be an all-around favorable trading session for the stock market, with the FTSE 100 Index UKX rising 0.54% to 8,854.18. GSK PLC ...

GSK specialty medicines grew YoY in Q1 2025, and it is now the main profit engine, offsetting the weakness in their vaccine segment. See why the stock is a Buy.